These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29414124)

  • 1. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
    Foo WC; Khong YM; Gokhale R; Chan SY
    Int J Pharm; 2018 Mar; 539(1-2):165-174. PubMed ID: 29414124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of miniaturized near-infrared spectroscopy for quality control of extemporaneous orodispersible films.
    Foo WC; Widjaja E; Khong YM; Gokhale R; Chan SY
    J Pharm Biomed Anal; 2018 Feb; 150():191-198. PubMed ID: 29247960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
    Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
    Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key acceptability attributes of orodispersible films.
    Scarpa M; Paudel A; Kloprogge F; Hsiao WK; Bresciani M; Gaisford S; Orlu M
    Eur J Pharm Biopharm; 2018 Apr; 125():131-140. PubMed ID: 29355687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased drug load and polymer compatibility of bilayered orodispersible films.
    Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
    Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy.
    Yan TT; Lv ZF; Tian P; Lin MM; Lin W; Huang SY; Chen YZ
    Drug Dev Ind Pharm; 2020 Apr; 46(4):531-538. PubMed ID: 32141352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
    Speer I; Preis M; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on disintegration methods for oral film preparations.
    Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
    Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation development of a continuously manufactured orodispersible film containing warfarin sodium for individualized dosing.
    Niese S; Quodbach J
    Eur J Pharm Biopharm; 2019 Mar; 136():93-101. PubMed ID: 30660692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
    Thabet Y; Lunter D; Breitkreutz J
    Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study.
    Visser JC; Wibier L; Mekhaeil M; Woerdenbag HJ; Taxis K
    Int J Clin Pharm; 2020 Apr; 42(2):436-444. PubMed ID: 32052239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PVA-based formulations as a design-technology platform for orally disintegrating film matrices.
    Kozakiewicz-Latała M; Dyba AJ; Marciniak D; Szymczyk-Ziółkowska P; Cieszko M; Nartowski KP; Nowak M; Karolewicz B
    Int J Pharm; 2024 Nov; 665():124666. PubMed ID: 39265848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized orodispersible films by hot melt ram extrusion 3D printing.
    Musazzi UM; Selmin F; Ortenzi MA; Mohammed GK; Franzé S; Minghetti P; Cilurzo F
    Int J Pharm; 2018 Nov; 551(1-2):52-59. PubMed ID: 30205128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the production methods of orodispersible films.
    Musazzi UM; Khalid GM; Selmin F; Minghetti P; Cilurzo F
    Int J Pharm; 2020 Feb; 576():118963. PubMed ID: 31857185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutics, Drug Delivery and Pharmaceutical Technology: A New Test Unit for Disintegration End-Point Determination of Orodispersible Films.
    Low A; Kok SL; Khong Y; Chan SY; Gokhale R
    J Pharm Sci; 2015 Nov; 104(11):3893-903. PubMed ID: 27524687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
    Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
    Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D printing of multilayered orodispersible films with in-process drying.
    Elbl J; Gajdziok J; Kolarczyk J
    Int J Pharm; 2020 Feb; 575():118883. PubMed ID: 31811925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOFTs - Structured orodispersible film templates.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orodispersible films - Recent developments and new applications in drug delivery and therapy.
    Morath B; Sauer S; Zaradzki M; Wagner AH
    Biochem Pharmacol; 2022 Jun; 200():115036. PubMed ID: 35427572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Dissolution Method for Oral Film Preparations with Modified Release Properties.
    Speer I; Preis M; Breitkreutz J
    AAPS PharmSciTech; 2018 Dec; 20(1):7. PubMed ID: 30560468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.